Tomas Blomquist is an experienced life science executive, having served as the CEO and President of Biotage from 2019 to January 2024. They held various leadership positions at leading companies, including Roche, Johnson & Johnson, and Abbott, and are currently a Non-Executive Director at OssDsign and Nolato. Tomas also previously managed multiple regions as General Manager at Analyticon Biotechnologies and Managing Director at Alere, Inc. They have completed advanced management programs at the Stockholm School of Economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices